AMR leads to delays in treatment thus increasing the risk of spreading resistant microorganisms and health-care costs and the economic burden to families and societies
Union Minister of Health and Family Welfare, Jagat Prakash Nadda, launched the second version of the National Action Plan on Antimicrobial Resistance (2025–29), in New Delhi. He was joined by Dr AK Sood, Principal Scientific Advisor; Punya Salila Srivastava, Union Health Secretary; Dr Rajiv Bahl, Secretary, Dept of Health Research and Dr Sunita Sharma, Director General of Health Services (DGHS).
Nadda emphasised that antimicrobial resistance (AMR) is a major public health concern that can only be addressed through collective action. He noted that the journey began in 2010 with initial discussions, followed by the launch of the first NAP-AMR in 2017.
Highlighting the gravity of the challenge, he stated that AMR poses significant risks, particularly in surgical procedures, cancer treatment, and other critical healthcare interventions. He added that the overuse and misuse of antibiotics has unfortunately become common practice, underscoring the urgency of corrective measures. Several important initiatives have been undertaken by various line ministries in this regard.
Nadda also pointed out that NAP-AMR 2.0 addresses the gaps identified in the first NAP-AMR by increasing the ownership of AMR-related efforts, strengthening inter-sectoral coordination and ensuring stronger engagement with the private sector. Asserting on the key strategies of AMR containment which are to be implemented under NAP AMR 2.0, he stated the importance of increasing awareness, education and training. He also highlighted the requirement of enhancing laboratory capacity and infection control in healthcare facilities. Nadda stressed on the importance of regular stakeholder meetings to resolve challenges promptly.
Dr AK Sood stated that the NAP-AMR 2.0 is timely initiative for generating a more coherent action plan which is aptly being released on the first day of the WHO’s World AMR Awareness Week (18-24 Nov). Noting that India is one of the pioneers in driving this initiative globally, he stated that AMR is a like a pandemic affecting many countries especially the developing countries in Asia and Africa.
Dr Sood highlighted some of the steps taken by India in countering the menace of AMR. He pointed out that Kerala and Gujarat are the first states to ban over-the-counter sales of antibiotics. Some antimicrobials and pesticides have also been banned for use in crops. “The India AMR Innovation Hub was established involving both national and international stakeholders to build a novel technology platform. It has helped in mobilizing resources, bringing out innovation and enhancing collaboration between multiple stakeholders,” he stated.
